Production (Stage)
Replimune Group, Inc.
REPL
$8.98
-$0.39-4.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.04% | 9.21% | 6.36% | 9.11% | 19.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.60% | 5.42% | 8.44% | 23.83% | 33.70% |
| Operating Income | -11.60% | -5.42% | -8.44% | -23.83% | -33.70% |
| Income Before Tax | -14.60% | -8.86% | -7.25% | -21.37% | -23.79% |
| Income Tax Expenses | 14.71% | -32.98% | 41.67% | -57.67% | 41.67% |
| Earnings from Continuing Operations | -14.60% | -8.71% | -7.30% | -21.16% | -23.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.60% | -8.71% | -7.30% | -21.16% | -23.82% |
| EBIT | -11.60% | -5.42% | -8.44% | -23.83% | -33.70% |
| EBITDA | -11.36% | -5.26% | -9.27% | -25.19% | -35.49% |
| EPS Basic | 2.12% | -0.69% | -2.44% | -10.66% | -8.10% |
| Normalized Basic EPS | 2.11% | -0.86% | -2.39% | -10.83% | -8.06% |
| EPS Diluted | 2.12% | -0.69% | -2.44% | -10.66% | -8.10% |
| Normalized Diluted EPS | 2.11% | -0.86% | -2.39% | -10.83% | -8.06% |
| Average Basic Shares Outstanding | 16.84% | 8.02% | 5.15% | 9.48% | 14.36% |
| Average Diluted Shares Outstanding | 16.84% | 8.02% | 5.15% | 9.48% | 14.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |